Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current status of nanomedicine in the chemotherapy of breast cancer
Ana Isabel Fraguas‐Sánchez, Cristina Martín‐Sabroso, Ana Fernández-Carballido, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 4, pp. 689-706
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management
Priti Tagde, Agnieszka Najda, Kalpana Nagpal, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2856-2856
Open Access | Times Cited: 88
A Review of Different Types of Liposomes and Their Advancements as a Form of Gene Therapy Treatment for Breast Cancer
Gloria Yi Wei Tseu, Khairul Azfar Kamaruzaman
Molecules (2023) Vol. 28, Iss. 3, pp. 1498-1498
Open Access | Times Cited: 57
Recent advances and clinical translation of liposomal delivery systems in cancer therapy
Jiayi Chen, Siyuan Hu, Man Sun, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 193, pp. 106688-106688
Open Access | Times Cited: 39
Drug uptake-based chemoresistance in breast cancer treatment
Helena Muley, Rut Fadó, Rosalía Rodríguez‐Rodríguez, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 113959-113959
Open Access | Times Cited: 110
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez, Marie Cohen, et al.
Pharmaceutics (2020) Vol. 12, Iss. 5, pp. 439-439
Open Access | Times Cited: 70
Cancer nanomedicine in preoperative therapeutics: Nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy
Xiaogang Qu, Dong Zhou, Jianpu Lu, et al.
Bioactive Materials (2022) Vol. 24, pp. 136-152
Open Access | Times Cited: 57
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic
Ana Isabel Fraguas‐Sánchez, Irene Lozza, Ana Isabel Torres‐Suárez
Cancers (2022) Vol. 14, Iss. 5, pp. 1198-1198
Open Access | Times Cited: 50
Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
Naveen Rajana, Aare Mounika, Padakanti Sandeep Chary, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 1024-1047
Closed Access | Times Cited: 48
Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response
Jesse Yu, Qingxin Mu, Millie Fung, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108108-108108
Open Access | Times Cited: 44
The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
Fan Yang, Qingjie He, Xiangpeng Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
An Overview of Saturated Cyclic Ethers: Biological Profiles and Synthetic Strategies
Qili Lu, Dipesh S. Harmalkar, Yongseok Choi, et al.
Molecules (2019) Vol. 24, Iss. 20, pp. 3778-3778
Open Access | Times Cited: 61
Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats
Yifan Tong, Richard C. Wang, Shuhai Sheng, et al.
Bioscience Biotechnology and Biochemistry (2020) Vol. 84, Iss. 6, pp. 1201-1210
Open Access | Times Cited: 50
Endoplasmic reticulum stress targeted therapy for breast cancer
Di Xu, Zhen Liu, Ming‐Xing Liang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment
Sofia Quintas, Ana Manuela Canha Borges, Maria José Oliveira, et al.
Small (2023)
Open Access | Times Cited: 19
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
Cristina Martín‐Sabroso, Ana Isabel Torres‐Suárez, Mario Alonso, et al.
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 14-14
Open Access | Times Cited: 38
Hypoxia-Responsive Stereocomplex Polymeric Micelles with Improved Drug Loading Inhibit Breast Cancer Metastasis in an Orthotopic Murine Model
Min Lü, Xu Huang, Xiaohui Cai, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 18, pp. 20551-20565
Open Access | Times Cited: 23
Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges
Mahfoozur Rahman, Obaid Afzal, Shehla Nasar Mir Najib Ullah, et al.
ACS Omega (2023) Vol. 8, Iss. 51, pp. 48625-48649
Open Access | Times Cited: 12
Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade
Muhammad Sohail, Wenna Guo, Luca Gallelli, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 19, pp. 3753-3772
Closed Access | Times Cited: 34
MicroRNAs in Cancer Treatment-Induced Cardiotoxicity
Laura Pellegrini, Sara Sileno, M D'agostino, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 704-704
Open Access | Times Cited: 33
Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
Silvia Voci, Agnese Gagliardi, Roberto Molinaro, et al.
Gels (2021) Vol. 7, Iss. 2, pp. 33-33
Open Access | Times Cited: 27
Aptamer-conjugated carbon nanotubes or graphene for targeted cancer therapy and diagnosis
Mahmood Barani, Mehrdad Khatami, Behzad Behnam, et al.
Elsevier eBooks (2023), pp. 277-294
Closed Access | Times Cited: 11
A Deep Eutectic Solvent‐Based Approach to Intravenous Formulation
Jayoung Kim, Yujie Shi, Christopher J. Kwon, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 18
Closed Access | Times Cited: 24
Nanoparticle drug delivery to target breast cancer brain metastasis: Current and future trends
Siddarth Kannan, Vinton W.T. Cheng
International Journal of Cancer (2023) Vol. 153, Iss. 6, pp. 1118-1129
Open Access | Times Cited: 9
Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody
Jiacui Liu, Ping Wang, Ben Huang, et al.
International Journal of Pharmaceutics (2022) Vol. 624, pp. 121969-121969
Closed Access | Times Cited: 15
Hyperthermia promotes exosome secretion by regulating Rab7b while increasing drug sensitivity in adriamycin-resistant breast cancer
Di Xu, Wenjuan Tang, Yi-Zhi Zhu, et al.
International Journal of Hyperthermia (2022) Vol. 39, Iss. 1, pp. 246-257
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top